ABERA — Abera Bioscience AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK90.58m
- SEK82.63m
Annual cashflow statement for Abera Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.64 | -9.16 | -19.4 | -16.8 | -1.12 |
| Depreciation | |||||
| Changes in Working Capital | 0.893 | -0.516 | -0.299 | -0.91 | 0.861 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.75 | -9.68 | -19.7 | -17.7 | -0.198 |
| Capital Expenditures | — | — | — | — | -1.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.025 | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | — | — | — | -0.025 | -1.13 |
| Financing Cash Flow Items | — | -2.37 | -0.892 | -0.009 | -0.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1 | 20.7 | 23.2 | 5.6 | 4.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.75 | 11 | 3.48 | -12.1 | 2.77 |